TY - JOUR
KW - Buprenorphine/administration & dosage/therapeutic use
KW - COVID-19
KW - California
KW - Emergency Service, Hospital/statistics & numerical data
KW - Humans
KW - Narcotic Antagonists/administration & dosage/therapeutic use
KW - Opioid-Related Disorders/drug therapy
KW - Outcome Assessment, Health Care
KW - Practice Patterns, Physicians'
KW - SARS-CoV-2
KW - Administration and dosage
KW - buprenorphine
KW - Emergency services
KW - Opiate Substitution Treatment
KW - opioid-related disorders
AU - A. A. Herring
AU - M. Kalmin
AU - M. Speener
AU - D. Goodman-Meza
AU - H. Snyder
AU - A. Campbell
AU - A. Moulin
AU - S. Shoptaw
A1 - 
AD - Department of Emergency Medicine and Internal Medicine, Highland Hospital-Alameda Health System, Oakland, CA, United States of America; California Bridge Program, Public Health Institute, United States of America; University of California, San Francisco, San Francisco, CA, United States of America. Electronic address: aherring@alamedahealthsystem.org.; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America.; Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States of America.; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America; Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States of America.; Department of Family and Community Medicine, University of California, San Francisco, San Francisco, CA, United States of America; California Bridge Program, Public Health Institute, United States of America.; California Bridge Program, Public Health Institute, United States of America; Department of Emergency Medicine, Marshall Medical Center, Placerville, CA, United States of America.; California Bridge Program, Public Health Institute, United States of America; Department of Emergency Medicine and Psychiatry, UC Davis Medical Center, Sacramento, CA, United States of America.; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Opioids & Substance Use
DO - 10.1016/j.jsat.2020.108260
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - . Published by Elsevier Inc
PY - 2021
SN - 1873-6483; 0740-5472; 0740-5472
SP - 108260
T1 - Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California
T2 - Journal of substance abuse treatment
TI - Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California
U1 - Education & Workforce; Opioids & Substance Use
U2 - 33612194
U3 - 10.1016/j.jsat.2020.108260
VL - 123
VO - 1873-6483; 0740-5472; 0740-5472
Y1 - 2021
Y2 - Apr
ER -